Chamber and committees

Data on full-time equivalent (FTE) secondary teachers by main and other subject taught is available in the Teacher Census Supplementary Statistics, here: https://www.gov.scot/publications/teacher-census-supplementary-statistics/

Information is not held on the subjects offered by individual schools as schools may be able to offer a subject even if they do not have a teacher for that subject in the staff census, for example through school-school or school-college partnerships.

We do not have plans at this stage to ask SFRS to become a statutory consultee in planning processes for these sites however, we will of course continue discussions with SFRS on this matter as and when appropriate.

SFRS have outlined they continually review and develop their operational response to any new and emerging technology to keep communities safe and are committed to work in collaboration with key partners to ensure the highest level of preparedness for potential incidents involving lithium-ion batteries or similar storage facilities.

The number of babies who have been recorded in the Scottish Birth Record (SBR) as admitted to Wishaw Neonatal Intensive Care Unit in (a) 2024 was 504 and (b) for the period 1 January 2025 to 31 March 2025 was 131.

Of these babies the number who were recorded as having an NHS board other than NHS Lanarkshire was (a) in 2024, 31 and (b) for 1 January 2025 to 31 March 2025, 21.

The NHS boards of residence for these babies included; NHS Ayrshire and Arran, NHS Dumfries and Galloway, NHS Fife, NHS Forth Valley, NHS Greater Glasgow and Clyde, NHS Highland, NHS Lothian, NHS Shetland and NHS Tayside.

Regional Chief Executives have worked with NHS Board teams and strategic planning leads to undertake modelling and capacity work to develop local implementation plans, including plans for staffing levels. It’s important that the whole multidisciplinary team are involved in developing local plans, including obstetric and maternity staff. We expect that staffing resources in the neonatal units will be reflective of the workforce required to deliver care under the new model.

The development of our new palliative care strategy – Palliative Care Matters for All - has been informed throughout by ongoing collaboration with relevant policy areas across Scottish Government, such as health and social care, housing, equalities and social security.

This co-design approach across Scottish Government will help ensure that palliative care is considered and reflected in other relevant policies, delivery plans and standards, and supports their outcomes.

Local Government have the statutory responsibility for education so this information is not held centrally.

Improving safety for the babies, families and staff is our utmost priority, which is why we are taking this step and why we have taken phased approach to transition, allowing time to build the right levels of capacity in all areas, with NHS Boards working towards full implementation by 2026.

We are working with Regional Planning Chief Executives to plan and deliver this service change, informed by the testing that has been underway since 2018 in Ayrshire and Fife, and supported by Scottish Government funding of over £6m since 2019.

The Annual Participation Measure is published by Skills Development Scotland. This publication began in 2016. The Scottish Borders local authority data is available in supplementary table 1.7a – https://www.skillsdevelopmentscotland.co.uk/publications-statistics/statistics/annual-participation-measure.

The Scottish Government welcomes the findings from Public Health Scotland’s (PHS) report on chimeric antibody receptor therapies (CAR-T) for haematological malignancies. The report, which is a collaboration between PHS and the Cancer Medicines Outcomes Programme (CMOP), describes the impact and clinical outcomes of cancer medicines in the real world and can be used to both analyse the outcomes from CAR-T therapies across Scotland and assist with planning future treatment pathways.

The report demonstrates that by developing, and refining, a robust and reliable process cancer medicines intelligence may be routinely generated to support informed decision making at individual, local, and national levels. The data assists healthcare professionals to understand the real-life impact of cancer medicines, supports clinical decision making by enabling a more individualised approach to the provision of cancer care using CAR-T therapies and helps ensure the safe and effective use of these complex medicines.

The Scottish Government welcomes the finding that eligible patients are increasingly accessing CAR-T therapies.

NHS Board Chief Executives have endorsed a three-centre regional service model for delivering CAR-T therapies across Scotland, in NHS Greater Glasgow and Clyde, NHS Grampian and NHS Lothian, to expand capacity and provide easier access for people requiring this treatment. This service delivery model fully commenced on 1 April 2025.